Celldex Therapeutics, Inc.
(NASDAQ : CLDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.25%83.070.9%$974.14m
KITEKite Pharma, Inc.
0.01%179.3216.1%$742.16m
CELGCelgene Corporation
0.39%144.451.1%$499.67m
AMGNAmgen Inc.
0.09%185.921.1%$483.58m
BIIBBiogen Inc.
-0.13%318.051.2%$421.81m
REGNRegeneron Pharmaceuticals, Inc.
1.46%439.022.7%$359.50m
ALNYAlnylam Pharmaceuticals, Inc
2.07%116.1610.7%$250.82m
ALXNAlexion Pharmaceuticals, Inc.
0.59%143.661.9%$230.32m
JUNOJuno Therapeutics, Inc.
-4.59%43.0714.6%$225.89m
VRTXVertex Pharmaceuticals Incorporated
-1.43%149.111.9%$208.37m
INCYIncyte Corporation
-1.41%109.292.6%$204.73m
ILMNIllumina, Inc.
-0.64%200.123.5%$158.39m
BLUEBluebird Bio, Inc.
1.17%130.2519.3%$143.09m
BMRNBioMarin Pharmaceutical Inc.
-0.92%94.084.4%$136.13m
CLVSClovis Oncology, Inc.
-2.76%76.4018.0%$132.69m

Company Profile

Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.